Loading stock data…
€140.95+3.35 (+2.43%)
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
MRK.DE in the Healthcare sector is trading at €140.95 with a market capitalization of $59.3B. Wall Street consensus targets €154.21 (14 analysts), implying a +9.4% move over the next 12 months. The stock is currently near its 52-week high of €148.80, remaining 10.6% above its 200-day moving average. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (EUR) | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
| Total Revenue | €5.28B↑ | €5.25B↓ | €5.32B↑ | €5.25B↑ | €5.13B |
| Gross Profit | €3.15B↑ | €3.03B↓ | €3.21B↑ | €2.96B↓ | €3.06B |
| Operating Income | €1.01B↑ | €892.00M↓ | €1.21B↑ | €547.00M↓ | €943.00M |
| Net Income | €735.00M↑ | €652.00M↓ | €902.00M↑ | €319.00M↓ | €659.00M |
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs...